Aslani, Mineva .

HRN: 14-85-49  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/31/2026
CIPROFLOXACIN 500MG (TAB)
03/31/2026
04/06/2026
PO
500 Mg
Bid
Infectious Diarrhea, UTI
Checking Initial Appropriateness 
04/01/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/01/2026
04/07/2026
IV
500 Mg
Q8h
Amoebiasis
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: